-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Initiates Coverage On Versigent with Buy Rating, Announces Price Target of $48

Benzinga·07/20/2026 09:34:52
Listen to the news
Goldman Sachs analyst Mark Delaney initiates coverage on Versigent (NYSE:VGNT) with a Buy rating and announces Price Target of $48.